Early immunohistochemistry studies of pulmonary LCNEC also showed this dichotomy, demonstrating alterations of RB1 and TP53 common in SCLC with other samples lacking alterations of RB1 or TP53. The gene discussed is TP53; the disease is large cell neuroendocrine carcinoma.